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Nanostructures of metal oxide semiconductors play signiﬁcant
roles in a variety of areas, such as biotherapy, pollutant treatment
and energy storage and conversion. The molybdenum oxide
(MoO3−x) nanostructures have shown promising applications
especially when used as photothermal treatment agents due to
their relatively low cost, facile synthesis and low toxicity. However,
the design and synthesis of eﬃcient MoO3−x nanomaterials with
tunable phases and morphologies for theragnosis of tumors
remains a challenge. In this work, hydrophilic MoO3−x with con-
trolled structures and phases was synthesized by a simple one-step
hydrothermal process. The as-obtained MoO2 nanoclusters
showed a desirable size of ∼40 nm in diameter exhibiting unique
properties as a theragnosis nanoplatform: (1) strong near-infrared
absorption, which is due to oxygen vacancies of the nanoclusters,
as proved by photoluminescence spectroscopy and X-ray photo-
electron spectroscopy; (2) excellent photothermal performance
with a photothermal conversion eﬃciency of up to 62.1%; and (3)
the image response of X-ray computed tomography (CT) and infra-
red thermal imaging for simultaneous diagnosis of tumors. This
study provided the facile synthetic strategy for controllable metal
oxide semiconductors and promoted the development of metal
oxides for theragnosis therapy of cancers.
Photothermal therapy (PTT) for cancer ablation has attracted
great research interest recently as an alternative to traditional
cancer treatments.1–3 Nanostructured metal oxide semi-
conductors with controlled phases and morphologies have
been extensively developed for various applications, such as
catalysis,4 energy storage5–7 and biotherapy,8,9 etc. Currently,
metal oxide nanomaterials with oxygen vacancies in their
crystal structures, such as WO3−x
10,11 and MoO3−x,
12,13 which
possess a localized surface plasmon resonance (LSPR)
phenomenon have demonstrated strong near-infrared (NIR,
700–1400 nm) absorption.14 These properties combined with
the deep penetration of NIR light through surface tissues
makes these materials potentially very eﬀective PTT agents.15,16
The MoO3−x nanostructures have shown promising appli-
cations especially when used as PTT agents due to their rela-
tively low cost, mild synthesis, excellent photothermal per-
formance and low toxicity.12,13,17 Remarkable achievements
have been made for MoO3−x around biomedical applications,
especially as PTT agents, but there remain prominent chal-
lenges such as materials synthesis procedures, size-controlled
MoO3−x nanostructures and improvement of photothermal
performance.13,18 Facile fabrication of MoO3−x nanostructures
was first realized by Song et al.17 They showed that compli-
cated post treatments of hydrophobic and less biocompatible
oleylamine molecules coated nanomaterials could be avoided.
However, the sizes of the nanostructures are relatively large
and not suitable for bioapplications. It is well-known that
often particle sizes larger than 100 nm will accumulate in the
vital organs, such as livers.19 The hysteretic clearance of those
materials from the organisms could cause serious toxicity and
lead to long-term inflammatory response. Quantum dots of
MoO3−x were synthesized for use as photoacoustic imaging
guided photothermal/photodynamic cancer treatment.
However, quantum dots suﬀer from the disadvantage of
shorter blood circulation time which is not in favor of the
uptake of PTT agents by tumors.12 All-in-One theragnosis
nanomaterials exhibiting excellent photothermal perform-
ances as well as the ability to diagnose cancers has become a
research hotspots. Molybdenum has strong X-ray attenuation
which can be used in diagnostic applications such as X-ray
computed tomography (CT) imaging.20 To the best of our
knowledge, there is no report related to one-step synthesis of
MoO3−x with suitable nanostructures for use as an eﬀective CT
and infrared thermal imaging guided PTT agents.
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Herein, we rationally designed a facile one-step hydro-
thermal method to synthesize MoO3−x materials with varied
nanostructures (nanotubes, nanoflakes, nanoflowers and
nanoclusters) by simply changing the temperature and
reagents used in the reactions. The as-obtained self-assembled
MoO2 nanoclusters can be used as the highly eﬃcient CT and
infrared thermal imaging guided PTT agents for cancer treat-
ment in vivo.
MoO3−x nanostructures with tunable phases and mor-
phologies were synthesized from one-step hydrothermal
process by using ammonium molybdate tetrahydrate as the
Mo source and polyethylene glycol 400 (PEG-400) as the reduc-
tant and the hydrophilic coating layer. The morphologies of
the as-obtained materials were firstly investigated by scanning
electron microscopy (SEM). By controlling the temperature of
the reactions at 90, 120, 150 or 180 °C, diﬀerent morphologies
of MoO3−x nanostructures i.e. nanocubes, nanoflakes, nano-
flowers and nanoclusters could be obtained. At lower tempera-
tures, the products are relatively large with the size of hun-
dreds of nanometers to several micrometers (Fig. 1a–c) and are
not suitable for PTT agents in vivo. To further detect the sizes
of the MoO3−x nanoclusters, high magnification SEM (Fig. 2a)
and transmission electron microscopy (TEM; Fig. 2b) images
were performed. The nanoclusters show a rough surface and
the BET surface area is ∼18 m2 g−1 (Fig. S1†). The average size
of nanoclusters observed from TEM was around 40 nm, while
that of nanoclusters measured by dynamic light scattering
(DLS) was around 80 nm (Fig. S2†), indicating that those nano-
clusters were mostly individually dispersed in the aqueous
solution, and had an appropriate size for use as a PTT agent.
High resolution TEM (HRTEM) images showed a lattice
spacing of 0.34 nm, which corresponds to the {11} facets of
tugarinovite MoO2. Further X-ray diﬀraction (XRD) patterns
demonstrated that all peaks of the samples corresponded to
standard MoO2 (JCPDS No. 32-0671) with no unmatched
peaks, indicating the sample is phase-pure. If PEG-400 is
moving from the precursor solutions, MoO3−x nanorods were
obtained at all temperature ranges. Fig. S3† shows the repre-
sentative morphology of MoO3−x nanorods synthesized at
180 °C. XRD patterns (Fig. S4†) showed the MoO3−x nanorods
could be indexed to the molybdite structure of MoO3 (JCPDS
No. 35-0609). The structures of tugrinovite (MoO2) and molyb-
dite (MoO3) are shown in Fig. S5a and 5b,† respectively. In
both structures, the Mo atoms possess oﬀ-centre positions in
the distorted MoO6 octahedral. Hence, the coordination geo-
metries of Mo are the same, Mo6+. The compositions and the
chemical states of MoO2 nanoclusters and MoO3 nanorods
were detected and compared by X-ray photoelectron spec-
troscopy (XPS). Fig. S6† depicted the Mo 3d and O 1s spectra
of MoO2 and MoO3 nanostructures, respectively. The curves of
Mo 3d spectra can be fitted into two groups of spin–orbit
doublets of MoO2. The paired peaks at 233.9 and 231.0 eV
can be attributed to Mo6+,12 while the doublets at 232.8 and
229.6 eV are assigned to Mo4+.21 However, just one doublet
(Fig. S6c†) from MoO3 can be detected, which resulted from
Mo6+.7 The major diﬀerence between the O 1s is at 532.6 eV,
assigned to –OH in carbon chains from the hydrophilic modi-
fication by PEG-400 of MoO2 nanoclusters.
22 In addition, the
obvious peaks corresponded to oxygen vacancies in the matrix
of metal oxides can be fitted to MoO2 nanostructures, this was
also proved by photoluminescence spectrum (Fig. S7†), which
is the primary reason for LSPR phenomenon of transitional
metal oxide materials.
It is well known that the surface chemistry of nanomaterials
is very important for their biological application. Polyethylene
glycol (PEG) is extensively applied to functionalize biomaterials
to improve their dispersity and biocompatibility.23,24 As a
result, the PEG coated MoO2 nanoclusters are hydrophilic
without any modification, and they can well be dispersed in
Fig. 1 SEM images of MoO2 nanostructures synthesized from diﬀerent
temperatures (a) nanocubes; (b) nanoﬂakes; (c) nanoﬂowers and (d)
nanoclusters. Scale bar: 1 μm.
Fig. 2 (a) High magniﬁcation SEM images of MoO2 nanoclusters; (b)
TEM image, (c) high magniﬁcation TEM (HRTEM) image of MoO2 nano-
clusters; (d) XRD patterns of MoO2 samples (blue index lines correspond
to standard pattern JCPDS No. 32-0671).
Nanoscale Communication
This journal is © The Royal Society of Chemistry 2017 Nanoscale, 2017, 9, 11012–11016 | 11013
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
Ju
ly
 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
3/
11
/2
01
7 
10
:5
3:
53
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
water, saline, and RPMI-1640 culture medium without any
noticeable agglomeration over a week (Fig. S8†) due to the
small size and PEG coating. Then, UV-vis absorbance spectra
were recorded for MoO2 nanoclusters and MoO3 nanorods.
Shown in Fig. 3a, compared with MoO3, MoO2 nanoclusters
presented stronger adsorption from 600–1000 nm with a peak
maximum at 800 nm. Based on this light absorption character,
an 808 nm laser was chosen to study the photothermal per-
formance of MoO2 nanoclusters. Under a continuous
irradiation laser with a power density of 0.5 W cm−2, the temp-
erature of diﬀerent concentration (0–500 ppm) of MoO2 nano-
clusters aqueous solutions was recorded. As shown in Fig. 3b
and Fig. S9,† the nanoclusters exhibited concentration-depen-
dent photothermal eﬀects, as a control, the temperature of
pure water showed little change (increase of 0.8 °C). The temp-
erature increases of the MoO2 nanoclusters aqueous dis-
persion change from 13.3 to 38.6 °C. We then measured the
photothermal conversion eﬃciency of MoO2 nanoclusters by a
modified method similar to the reports on Cu7.2S4 nanocrys-
tals.25 According to the obtained date shown in Fig. 3b and
Fig. S10,† the 808 nm laser heat conversion eﬃciency of MoO2
nanoclusters can be calculated to be 62.1%, which is among
the highest values in semiconductor materials as PTT, such as
28.1% for WO3−x hierarchical nanostructures, 54.8% for RuO2
nanoparticles,26 32.8% for WS2 nanosheets,
27 and 22% for
Cu2−xSe nanocrystals.
28 The high photothermal conversion
eﬃciency should be attributed to the strong NIR absorption
resulted from the oxygen-deficiency-induced small polarons in
MoO2 nanoclusters and eﬀective nonradiative electron relax-
ation dynamics,29 as well as the special structure of MoO2
nanoclusters which can serve as excellent laser-cavity mirrors
of a 808 nm laser.30 What’s more, the as-prepared MoO2 nano-
clusters showed great NIR photostability without any signifi-
cant decrease in the optical absorbance even upon a long time
irradiation by a 2 W, 808 nm laser, whereas Au nanorods dis-
played notable changes in their optical properties (Fig. S11†).
These results indicated that MoO2 nanoclusters can be a prom-
ising 808 nm-laser-driven photothermal agent.
Prior to realizing the PTT in vivo, we evaluated the photo-
thermal cytotoxicity of MoO2 nanoclusters with and without
laser irradiation on TC71 cells by CCK8 assay. These MoO2
nanoclusters appeared to have low toxicity without NIR light
irradiation. The cell viability was about 80% even at a high
concentration up to 1000 ppm (Fig. S12a†). However, when
simultaneously treatments with MoO2 nanoclusters and
808 nm laser illumination (0.5 W cm−2, 5 min), the cell viabil-
ities significantly decreased as the concentration increased
(Fig. S12b†). The in vivo therapeutic eﬃcacy of the MoO2 nano-
clusters (250 ppm)-induced photothermal therapy cancer treat-
ment using an 808 nm laser (0.5 W cm−2) for 5 min was
studied. All animal experiments were performed in accordance
with the guidelines of the Institutional Animal Care and Use
Committee of Shanghai JiaoTong University. The mice were
randomly divided into four groups and then diﬀerently
treated: (a) PBS solution, (b) MoO2 nanoclusters, (c) MoO2
nanoclusters + NIR laser 5 min, and (d) PBS + NIR laser 5 min.
The mice from group (a) and (b) as a control were not irra-
diated, while the mice from group (c) and (d) were simul-
taneously exposed to an 808 nm laser. During the laser treat-
ment, full-body infrared thermal images were captured using
an IR camera. As shown in the inset of Fig. 3c, it can be clearly
noticed that the region 11 framed area injected with the MoO2
nanoclusters generates a greater temperature increase under
irradiation, while, as a control, limited temperature change
was detected in the region 12 framed area. The temperature of
the irradiated area was also recorded as a function of the
irradiation time (Fig. 3c). For the mouse injected with saline
solution (region 12), the surface temperature of the tumor
increased by less than 2 °C. However, in the case of the MoO2
nanoclusters-injected mouse (region 11), the tumor surface
temperature increased rapidly and reached up to 53.6 °C after
50 s, and then change to plateau at about 53.5 ± 0.7 °C. These
results reveal a rapid elevation of temperature of the in vivo
tumor, which suggests that the MoO2 nanoclusters in vivo have
an excellent photothermal eﬀect. To further evaluate photo-
thermal ablation of cancer cells in vivo, the histological exam-
ination of tumors was performed a day after treatments by
means of microscopic imaging (Fig. 3d). As expected, signifi-
cant cancer cell damage was noticed only in the tumor with
both MoO2 nanostructures injection and laser irradiation, but
not in the three control groups. The experimental group shows
severe cellular damage (pyknosis, karyorrhexis and karyolysis).
Fig. 3 (a) UV-vis absorbance spectra for the aqueous dispersion of the
MoO2 (blue line) and MoO3 (red line) nanostructures synthesized at
180 °C. (b) Temperature elevation of the pure water and the aqueous
dispersion of the MoO2 nanoclusters with diﬀerent concentrations
under the irradiation of an 808 nm laser with a power density of 0.5
W cm−2 as a function of irradiation time (0–300 s). (c) The temperature
proﬁles in region 11 and 12 as a function of the irradiation time. Insert:
Infrared thermal images of two mice injected with the MoO2 nano-
clusters (the left mouse, indicated region 12) or saline (the right mouse,
indicated region 11) via the hypodermic injection, respectively, irradiated
with 808 nm laser (0.5 W cm−2) at a time point of 0 and 60 s. (d) The
representative hematoxylin and eosin stained histological images of the
corresponding ex vivo tumor sections. Scale bar: 100 μm.
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In the control groups, there are no obvious diﬀerences regard-
ing the cells’ size and shape, nuclear modifications, or necro-
sis. These facts suggest that in vivo cancer cells can be eﬃcien-
tly destroyed by the excellent photothermal eﬀect of MoO2
nanoclusters.
Fig. 4a presents the CT image of an aqueous dispersion of
the MoO2 nanoclusters at diﬀerent concentrations. We can
clearly observe that CT signal intensity is enhanced with an
increase in the concentrations. Meanwhile, the Hounsfield
Units (HU) values increased linearly with the concentration for
the MoO2 nanostructures as shown in Fig. 4b. The slope of the
HU value was about 15.1 HU L g−1. We then studied in vivo CT
imaging using the MoO2 nanostructures as a CT contrast
agent. These MoO2 nanoclusters dispersed in a PBS solution
were intratumorally injected into a tumor-bearing mouse.
Fig. 4c shows the in vivo tumor CT images before and after
intratumoral injection with the MoO2 solution (100 μL,
10 000 ppm). The corresponding injection site exhibited a
brighter contrast than other soft tissues. Meanwhile, the mean
CT value of the injection sites is much higher than the value
of the soft tissues. The CT value of the tumor area post-injec-
tion was significantly higher than that of the tumor area
before injection (a mean value: 147 versus 15). Therefore, these
results obviously indicated that the MoO2 nanostructures can
be a promising CT contrast agent in vivo.
In conclusion, by controlling the reductants and reaction
temperature in the hydrothermal synthesis, various phases
and morphologies of MoO3−x nanostructures can be syn-
thesized. MoO2 nanoclusters obtained at 180 °C have a size of
40 nm and can be used for bioapplications. Due to the
intense NIR absorption and high photothermal conversion of
62.1%, MoO2 nanoclusters were used as the PTT agents to kill
cancer cells in vitro and in vivo eﬃciently under the
irradiation of an 808 nm laser at a safe intensity of 0.5
W cm−2. In addition, the CT response are reported for the
first time of this kind of metal oxides. Therefore, MoO2 nano-
clusters are promising candidates for theragnosis therapy of
cancers.
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